Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
CBP inhibitor
DRUG CLASS:
CBP inhibitor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
PRI724 (5)
CCS1477 (4)
FT-6876 (1)
AU-18069 (0)
AUR-107 (0)
E7386 (0)
EP31670 (0)
NEO1132 (0)
PRI724 (5)
CCS1477 (4)
FT-6876 (1)
AU-18069 (0)
AUR-107 (0)
E7386 (0)
EP31670 (0)
NEO1132 (0)
›
Associations
(10)
News
Trials
VERI cancer hierarchy
Reset Filters
CTNNB1 mutation
Endometrial Cancer
CTNNB1 mutation
Endometrial Cancer
PRI724 + SM04690
Sensitive: B - Late Trials
PRI724 + SM04690
Sensitive
:
B
PRI724 + SM04690
Sensitive: B - Late Trials
PRI724 + SM04690
Sensitive
:
B
No biomarker
Multiple Myeloma
No biomarker
Multiple Myeloma
CCS1477
Sensitive: B - Late Trials
CCS1477
Sensitive
:
B
CCS1477
Sensitive: B - Late Trials
CCS1477
Sensitive
:
B
AR positive
Breast Cancer
AR positive
Breast Cancer
FT-6876
Sensitive: D – Preclinical
FT-6876
Sensitive
:
D
FT-6876
Sensitive: D – Preclinical
FT-6876
Sensitive
:
D
CTNNB1 expression
Hepatocellular Cancer
CTNNB1 expression
Hepatocellular Cancer
PRI724
Sensitive: D – Preclinical
PRI724
Sensitive
:
D
PRI724
Sensitive: D – Preclinical
PRI724
Sensitive
:
D
MYC expression
Multiple Myeloma
MYC expression
Multiple Myeloma
lenalidomide + CCS1477
Sensitive: D – Preclinical
lenalidomide + CCS1477
Sensitive
:
D
lenalidomide + CCS1477
Sensitive: D – Preclinical
lenalidomide + CCS1477
Sensitive
:
D
IRF4 expression
Multiple Myeloma
IRF4 expression
Multiple Myeloma
lenalidomide + CCS1477
Sensitive: D – Preclinical
lenalidomide + CCS1477
Sensitive
:
D
lenalidomide + CCS1477
Sensitive: D – Preclinical
lenalidomide + CCS1477
Sensitive
:
D
MYC expression
Acute Myelogenous Leukemia
MYC expression
Acute Myelogenous Leukemia
CCS1477
Sensitive: D – Preclinical
CCS1477
Sensitive
:
D
CCS1477
Sensitive: D – Preclinical
CCS1477
Sensitive
:
D
RBMS3 deletion
Ovarian Cancer
RBMS3 deletion
Ovarian Cancer
PRI724
Sensitive: D – Preclinical
PRI724
Sensitive
:
D
PRI724
Sensitive: D – Preclinical
PRI724
Sensitive
:
D
BOP1 overexpression
Triple Negative Breast Cancer
BOP1 overexpression
Triple Negative Breast Cancer
PRI724
Sensitive: D – Preclinical
PRI724
Sensitive
:
D
PRI724
Sensitive: D – Preclinical
PRI724
Sensitive
:
D
CTNNB1 S45P
Hepatocellular Cancer
CTNNB1 S45P
Hepatocellular Cancer
PRI724
Sensitive: D – Preclinical
PRI724
Sensitive
:
D
PRI724
Sensitive: D – Preclinical
PRI724
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.